Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • EFFECT OF MISSENSE VARIATIONs: REVELEALED

Govt State AIDS Control Society Quality Manager Recruitment

RC-PCR technology in SARS-Cov-2: Mega-Analyzer for outbreaks

EFFECT OF MISSENSE VARIATIONs: REVELEALED
  • BiotechToday
  • World

EFFECT OF MISSENSE VARIATIONs: REVELEALED

bioxone November 1, 2020November 1, 2020

DEEPON CHAKRABORTY, UNIVERSITY OF CALCUTTA

Interpretation of a large number of genetic variants identified from sequencing is one of the breakthroughs of clinical genetics. It is also termed as genetic screening. The main challenge is the identification of the effect of amino acid substituting missense variation on protein structure and function. Its several applications are coming out each day especially for the diagnosis of rare monogenic diseases and cancer.

It has several applications, among which identification of a rapidly growing number of genetic variations is noteworthy. These genetic variations are mostly missense variations which cause an amino acid substitution upon a single nucleotide change in the protein-coding region of the genome. These missense variations can be either benign or pathogenic and the most important thing is that both types coexist in almost every disease-associated gene. By knowing the consequence of amino acid substitution on the protein structure and function we can Discover how a missense variant is implicated in a disease. The ability to predict pathogenicity is improving day by day but the output scores of the predictors do not advance our knowledge about the molecular pathology of associated disorders. So, various in-silico methods are employed in pathogenicity prediction and it employs a variety of machine learning algorithms which are based on various pathogenic and population variant data which uses many features such as evolutionary pieces of information, gene-level properties and specific amino acid exchanges in protein sequences.

Biological insights into the effect of pathogenic missense variations can be gained by analysing the relationship between point mutations and protein structures. Several studies in this field focus light on the fact that the damaging consequences of missense variations are linked to the properties and localisation of the altered amino acid residues in the protein structure. Several resources have been developed to predict the impact of amino acid substitution on protein structure. Some of them are missense 3D, SuSPect, VarSite etc. They can predict a change in structure, free energy etc. due to mutation. 

American College of Medical Genetics and Genomics (ACMG) propose some guidelines where they list the presence of an amino acid substitution in mutational hotspot as moderate evidence of pathogenicity. A mutational hotspot is a site that displays frequent occurrence of pathogenic mutations and depleted in benign variants. that hotspot can be located at a region of the protein known to be critical for its function or functional domain and also in less well-characterized regions too.

Recently some scientist of MIT, Harvard, Cambridge and some renowned worldwide institution had tried to bridge the gap between genetic variation data and Molecular phenotype. They are mainly focusing on the analysis of features of single amino acid in the context of the native 3D protein structure. We can conclude that the 3D sites those are more frequently mutated in pathogenic variants than benign variants are more likely to be important in protein fitness and it contributes more in the determination of pathogenicity. In near future, it is easier and in hand to determine variant pathogenicity based on this approach.

Also read:Arabidopsis thaliana- A hero in disguise?

REFERENCE: http://feedproxy.google.com/~r/PnasRssFeedOfEarlyEditionArticles/~3/DbDO95AU_pc/2002660117.short?utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged American College of Medical Genetics and Genomics amino acid substitution Cambridge cancer cytoskeletal proteins genetic screening genetic variation Harvard in-silico methods missense 3D missense mutation MISSENSE VARIATION MIT molecular phenotype monogenic diseases Mutation mutational hotspot functional domain point mutation protein structures US

2 thoughts on “EFFECT OF MISSENSE VARIATIONs: REVELEALED”

  1. Pingback: Moderna: Covid-19 Vaccine- Sooner than we think? - BioXone
  2. Pingback: Inducing DNA-protein crosslinks and 5-azacytidine to study genetic mutation in Escherichia coli - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

RC-PCR technology in SARS-Cov-2: Mega-Analyzer for outbreaks

bioxone November 1, 2020

 Ayooshi Mitra, Amity University Kolkata Present transmission rates of SARS-CoV-2 are still on the rise, with second waves of infections being faced by many countries. Rapid SARS-CoV-2 whole-genome sequencing (WGS) is a massive tool for tracking and assessing transmission links but is not so readily available.  In a study conducted by a group of researchers, […]

RC-PCR

Related Post

  • BiotechToday
  • World

HIV vaccine trials re-initiated at Oxford after 40 years

BioTech Today July 10, 2021July 10, 2021

Sneha Singhal, Jaypee Institute of information technology, Noida Oxford University researchers have announced that volunteers have received the first HIV (Human immunodeficiency) vaccination to find an effective cure for the virus. It has been 40 years since an effective HIV vaccine has been discovered. Trials are underway to develop an effective vaccine against HIV. The […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Computational biology approaches help accelerate vaccine development

BioTech Today September 16, 2021September 16, 2021

Debarati Basu, Makaut WB Identification of antigen is a major step for the development of the vaccine. Artificial intelligence including deep learning systems is useful for identifying vaccine targets utilizing genomic and proteomic information. An artificial intelligence-based platform was developed by the researchers of Amity University, Noida, and Baylor College of Medicine in Houston, USA. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

98.6F Vs New Normal: Why the body temperature is declining over time?

bioxone November 1, 2020October 31, 2020

Dyotak Chandra, The West Bengal University Of Health Sciences Since the past two centuries, 98.6°F (37C) is taken as the standard “normal” body temperature. First established by German physician Carl Wunderlich, it has been used by doctors and parents as a measure by which fever can be assessed and to detect the severity of any […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy